Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000985598 | SCV001133924 | uncertain significance | not provided | 2019-05-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002409313 | SCV002676026 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-07-06 | criteria provided, single submitter | clinical testing | The p.L2736V variant (also known as c.8206C>G), located in coding exon 17 of the BRCA2 gene, results from a C to G substitution at nucleotide position 8206. The leucine at codon 2736 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003461296 | SCV004216137 | uncertain significance | Familial cancer of breast | 2023-05-16 | criteria provided, single submitter | clinical testing |